Acumen Pharmaceuticals (ABOS) EPS (Diluted) (2021 - 2026)
Acumen Pharmaceuticals (ABOS) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 0.15 |
| 10 | Acumen Pharmaceuticals | 229.68 Mn | 229.68 Mn | - | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.51 |
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -0.41 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -0.67 |
| Mar 31, 2025 | -0.48 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | -0.50 |
| Jun 30, 2024 | -0.36 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.35 |
| Sep 30, 2022 | -1.26 |
| Jun 30, 2022 | -0.57 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.42 |
| Sep 30, 2021 | -0.10 |